Selected article for: "acute infection occur and long covid"
Author: Lin, Jieru E.; Asfour, Arsenoi; Sewell, Taylor B.; Hooe, Benjamin; Pryce, Patrice; Earley, Chelsea; Shen, Min Ye; Kerner-Rossi, Mallory; Thakur, Kiran T.; Vargas, Wendy S.; Silver, Wendy G.; Geneslaw, Andrew S.
Title: Neurological issues in children with COVID-19
  • Cord-id: swmvsa0b
  • Document date: 2021_1_19
    • ID: swmvsa0b
    Snippet: Coronavirus disease 2019 (COVID-19) usually leads to a mild infectious disease course in children, but serious complications may occur in conjunction with both acute infection and associated phenomena such as the multisystem inflammatory syndrome in children (MIS-C). Neurological symptoms, which have been predominantly reported in adults, range from mild headache to seizure, peripheral neuropathy, stroke, demyelinating disorders, and encephalopathy. Similar to respiratory and cardiac manifestati
    Document: Coronavirus disease 2019 (COVID-19) usually leads to a mild infectious disease course in children, but serious complications may occur in conjunction with both acute infection and associated phenomena such as the multisystem inflammatory syndrome in children (MIS-C). Neurological symptoms, which have been predominantly reported in adults, range from mild headache to seizure, peripheral neuropathy, stroke, demyelinating disorders, and encephalopathy. Similar to respiratory and cardiac manifestations of COVID-19, neurological complications present differently based on age and underlying comorbidities. This review provides a concise overview of the neurological conditions seen in the context of COVID-19, as well as potential mechanisms and long-term implications of COVID-19 in the pediatric population from literature reviews and primary data collected at NewYork-Presbyterian Morgan Stanley Children's Hospital.

    Search related documents:
    Co phrase search for related documents
    • ace receptor and active infection: 1
    • ace receptor and acute phase: 1, 2, 3
    • ace receptor and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace receptor and ade antibody dependent enhancement: 1, 2
    • ace receptor virus and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7
    • active infection and acute phase: 1, 2, 3, 4, 5, 6, 7
    • active infection and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active infection and adaptive immune activation: 1
    • active infection and adequate treatment: 1, 2
    • active infection and long term impact: 1, 2, 3
    • active infection indicative and acute sars respiratory syndrome coronavirus: 1
    • acute phase and adaptive immune activation: 1, 2
    • acute phase and ade antibody dependent enhancement: 1
    • acute phase and adequate treatment: 1, 2, 3
    • acute phase and long term dysfunction: 1
    • acute phase and long term impact: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute sars respiratory syndrome coronavirus and adaptive immune activation: 1, 2, 3, 4, 5, 6, 7
    • acute sars respiratory syndrome coronavirus and ade antibody dependent enhancement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars respiratory syndrome coronavirus and long term dysfunction: 1, 2, 3